![Seamus Mulligan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seamus Mulligan
Direktor/Vorstandsmitglied bei
JAZZ PHARMACEUTICALS PLC
Vermögen: 322 Mio $ am 31.08.2026
Profil
Seamus C.
Mulligan was the founder of Azur Pharma Ltd., founded in 2005, where the title held was Chairman & Chief Executive Officer from 2005 to 2012.
Current jobs include Independent Director at Jazz Pharmaceuticals, Inc. since 2012 and Independent Director at Jazz Pharmaceuticals Plc since 2013.
Former jobs include Chairman & Chief Executive Officer at Emergent BioSolutions Ireland Ltd. from 2014 to 2018, Executive Chairman at Circ Pharma Ltd. from 2006 to 2017, Director at Emergent BioSolutions, Inc. from 2019 to 2020, Director at National Pharmaceutical Council, and Executive VP-Business & Corporate Development at Elan Corp.
Plc from 1984 to 2004.
Education includes undergraduate and graduate degrees from Trinity College Dublin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.08.2026 | 1.286.254 ( 1,98 % ) | 322 Mio $ | 31.08.2026 |
Aktive Positionen von Seamus Mulligan
| Unternehmen | Position | Beginn |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 18.01.2012 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Direktor/Vorstandsmitglied | 01.01.2012 |
Ehemalige bekannte Positionen von Seamus Mulligan
| Unternehmen | Position | Ende |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Direktor/Vorstandsmitglied | 21.05.2020 |
Emergent BioSolutions Ireland Ltd.
 Emergent BioSolutions Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic treatments for patients with special medical conditions | Vorstandsvorsitzender | 01.10.2018 |
Circ Pharma Ltd.
 Circ Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Vorsitzender | 01.04.2017 |
Azur Pharma Ltd.
 Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 26.01.2012 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Seamus Mulligan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
Circ Pharma Ltd.
Circ Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Emergent BioSolutions Ireland Ltd.
Emergent BioSolutions Ireland Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic treatments for patients with special medical conditions | Health Technology |
